SEARCH RESULTS FOR: "Tag: AMRN"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(4)
2018(6)
2015(3)
CATEGORIES
Analyst Update(1)
Buzz Stocks(2)
General(3)
Midday Market Check(1)
Quantitative Analysis(2)
Stocks On the Move(4)
Technical Analysis(1)

3/28/2019 10:08 AM
Amarin Corporation (NASDAQ:AMRN) stock is up 4.5%% to trade at $18.75, after the American Diabetes Association (ADA) recommended Vascepa, Amarin's fish oil-based triglyceride treatment, for patients w...
3/20/2019 2:51 PM
Pharmaceutical concerns Sarepta Therapeutics Inc (NASDAQ:SRPT) and Amarin Corporation (NASDAQ:AMRN) have recently retreated from new highs. However, both stocks are approaching key levels that could ...
2/22/2019 2:57 PM
The Dow is sailing toward its longest weekly win streak in 23 years on hopes of a U.S.-China trade deal. Among individual stocks making notable moves are shipping specialist Pitney Bowes Inc. (NYSE:...
1/10/2019 2:57 PM
Stocks are cautiously higher, but gains are capped by subpar holiday sales data. Among stocks making notable moves higher today are beer maker Constellation Brands, Inc. (NYSE:STZ), cardiovascular di...
12/19/2018 12:30 PM
Despite today's gains, the healthcare sector has been under pressure lately amid the recent Obamacare court ruling. If history is any guide though, there could be clear skies ahead for blue chip Merc...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center